Longevity Therapeutics Summit 2022
June 28-30 sees this industry event return to San Francisco
The pursuit for the first approved longevity drug to treat the mechanisms of aging has never been more exciting with our understanding of the underlying biology of aging evolving and many innovative therapeutic options making significant preclinical and clinical progress.
The unmissable 4th Annual Longevity Therapeutics Summit is returning in-person to San Francisco this June 28-30 where it remains the only industry meeting uniting 100+ leading biotech/pharma drug developers, pioneering academics, and prominent investors striving to develop effective, novel anti-aging drugs and overcome major preclinical, translational, clinical, and regulatory obstacles.
With over 10 hours dedicated solely to in-person networking and discussion, this is a must-attend meeting of 2022 to reunite with peers in the longevity field and share ideas and opinions to help cure age-related diseases and ultimately aging.
Download the official brochure to find out more about this year’s summit.
About the author
Steve serves on the LEAF Board of Directors and is the Editor in Chief, coordinating the daily news articles and social media content of the organization. He is an active journalist in the aging research and biotechnology field and has to date written over 600 articles on the topic, interviewed over 100 of the leading researchers in the field, hosted livestream events focused on aging, as well as attending various medical industry conferences.
His work has been featured in H+ magazine, Psychology Today, Singularity Weblog, Standpoint Magazine, Swiss Monthly, Keep me Prime, and New Economy Magazine.
Steve is one of three recipients of the 2020 H+ Innovator Award and shares this honour with Mirko Ranieri – Google AR and Dinorah Delfin – Immortalists Magazine. The H+ Innovator Award looks into our community and acknowledges ideas and projects that encourage social change, achieve scientific accomplishments, technological advances, philosophical and intellectual visions, author unique narratives, build fascinating artistic ventures, and develop products that bridge gaps and help us to achieve transhumanist goals.
Steve has a background in project management and administration which has helped him to build a united team for effective fundraising and content creation, while his additional knowledge of biology and statistical data analysis allows him to carefully assess and coordinate the scientific groups involved in the project.
Write a comment: